Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

NewsGuard 100/100 Score

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American Society of Echocardiography (ASE) annual meeting in Montreal, June 11-14, 2011 (Booth #1019), Toshiba America Medical Systems, Inc., will highlight cardiac and shared service ultrasound applications designed to improve cardiac ultrasound imaging.

Further demonstrating Toshiba's leadership in cardiac ultrasound, the Aplio™ cardiovascular system tied for first overall in KLAS' latest report, "Echo 2011: A Tight Race at the Top." The Aplio's advanced cardiac applications make it easy to perform a variety of high-end cardiology exams in multiple clinical settings, and the KLAS distinction is another example of Toshiba's commitment to developing industry-leading ultrasound technology. According to one Toshiba customer comment in the report, "[The Aplio cardiovascular system] is loaded with great functionality. It is mobile and easy to move… The image quality is excellent and the Doppler is very good."

"Toshiba is dedicated to developing imaging systems to meet the needs of healthcare providers," said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. "These enhancements to the ultrasound product line and our top customer ratings show that Toshiba's advanced technology enables quicker, safer and more effective diagnosis, particularly for cardiac exams."

Source:

Toshiba America Medical Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Progesterone more effective than cervical pessary at reducing the risk of severe preterm birth